Jan O. Lötvall - Nanotechnology

Author Information

Jan O. Lötvall is affiliated with the Krefting Research Centre, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. His research primarily focuses on extracellular vesicles and their implications in various medical conditions, including cancer immunotherapy and airway inflammation.

Research Contributions

Jan O. Lötvall has made significant contributions to the field of nanotechnology and extracellular vesicles. His work spans a variety of applications, including the use of synthetic bacterial vesicles in cancer immunotherapy and the characterization of extracellular vesicle subpopulations from tissues. His research also delves into the role of immune-associated proteins in lung tissue-derived extracellular vesicles during allergen-induced eosinophilic airway inflammation. He has been a part of initiatives to update the minimal requirements for studies of extracellular vesicles, reflecting his leadership in the field. Additionally, he has explored the implications of extracellular vesicles in the context of COVID-19 and obesity-related airway inflammation.

Aliases

Jan O. Lötvall is known by several aliases including J. Lötvall, J O Lötvall, Jan O. Lötvall, Jan Lötvall, J. O. Lötvall, and Jan Lö̈tvall.

Publication and Citation Metrics

Metric	Value
Total Citation Count	50,528
H-index	87
Total Paper Count	416

Publications:

A brief history of nearly EV‐erything – The rise and rise of extracellular vesicles

DOI: 10.1002/jev2.12144

Year: 2021

Immune-Associated Proteins Are Enriched in Lung Tissue-Derived Extracellular Vesicles during Allergen-Induced Eosinophilic Airway Inflammation

DOI: 10.3390/ijms22094718

Year: 2021

[High correlation between the different measures suggests that mortality is relatively correctly reported in Sweden].

DOI:

Year: 2021

Synthetic bacterial vesicles combined with tumour extracellular vesicles as cancer immunotherapy

DOI: 10.1002/jev2.12120

Year: 2021

Isolation and characterization of extracellular vesicle subpopulations from tissues.

DOI: 10.1038/s41596-020-00466-1

Year: 2021

Updating MISEV: Evolving the minimal requirements for studies of extracellular vesicles

DOI: 10.1002/jev2.12182

Year: 2021

818 Synergistic cancer immunotherapy using tumor tissue-derived exosomes and artificially produced bacterial outer membrane vesicles

DOI: 10.1136/jitc-2020-sitc2020.0818

Year: 2020

ISEV and ISCT statement on EVs from MSCs and other cells: considerations for potential therapeutic agents to suppress COVID-19

DOI:

Year: 2020

Lung Regulatory T Cells Express Adiponectin Receptor 1: Modulation by Obesity and Airway Allergic Inflammation

DOI: 10.3390/ijms21238990

Year: 2020

Decreased COPD prevalence in Sweden after decades of decrease in smoking

DOI: 10.1186/s12931-020-01536-4

Year: 2020

What is Slow Scan Speed?

Why is Quantum Mechanics Important in Nanotechnology?

How Does Magnetic Resonance Apply to Nanotechnology?

How Do Nanomaterials Contribute to Smarter Systems?

How Does AFM Work in NDT for Nanotechnology?

Why is Sentiment Analysis Important in Nanotechnology?

What is a Genetic Algorithm?

What Role Do Photonic Crystals Play?

Why is Endosomal Escape Important?

What is Surface Grafting?

Partnered Content Networks

Relevant Topics